These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 10626074)
21. Platelet aggregation and thrombosis in xenotransplantation between pigs and humans. Zhang B; Zhang A; Zhao Y Thromb Res; 2008; 121(4):433-41. PubMed ID: 17644165 [TBL] [Abstract][Full Text] [Related]
22. Xenotransplantation. Kaufman CL; Gaines BA; Ildstad ST Annu Rev Immunol; 1995; 13():339-67. PubMed ID: 7612227 [TBL] [Abstract][Full Text] [Related]
23. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection. Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290 [No Abstract] [Full Text] [Related]
25. Role of complement in graft rejection after organ transplantation. Bos IG; Ten Berge IJ; Hack CE Transfus Med Rev; 2002 Jul; 16(3):251-64. PubMed ID: 12075562 [TBL] [Abstract][Full Text] [Related]
27. Complement regulation in the GalT KO era. Miyagawa S; Yamamoto A; Matsunami K; Wang D; Takama Y; Ueno T; Okabe M; Nagashima H; Fukuzawa M Xenotransplantation; 2010; 17(1):11-25. PubMed ID: 20149185 [TBL] [Abstract][Full Text] [Related]
28. Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection. Winkler M Transplant Proc; 2001; 33(7-8):3862-4. PubMed ID: 11750645 [No Abstract] [Full Text] [Related]
29. Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model. Fiane AE; Videm V; Lambris JD; Geiran OR; Svennevig JL; Mollnes TE Transplant Proc; 2000 Aug; 32(5):899-900. PubMed ID: 10936264 [No Abstract] [Full Text] [Related]
31. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Rieben R; Seebach JD Trends Immunol; 2005 Jan; 26(1):2-5. PubMed ID: 15629401 [TBL] [Abstract][Full Text] [Related]
32. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711 [TBL] [Abstract][Full Text] [Related]
33. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270 [TBL] [Abstract][Full Text] [Related]
34. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection. Cary N; Moody J; Yannoutsos N; Wallwork J; White D Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815 [No Abstract] [Full Text] [Related]
35. The Role of Complement in Organ Transplantation. Grafals M; Thurman JM Front Immunol; 2019; 10():2380. PubMed ID: 31636644 [TBL] [Abstract][Full Text] [Related]